Kevin D. Kreutter
Janssen Pharmaceutica
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Kevin D. Kreutter.
Bioorganic & Medicinal Chemistry Letters | 2017
David A. Kummer; Maxwell D. Cummings; Marta Cristina Abad; Joseph Kent Barbay; Glenda Castro; Ronald L. Wolin; Kevin D. Kreutter; Umar Maharoof; Cynthia M. Milligan; Rachel Nishimura; Joan Pierce; Celine Schalk-Hihi; John Spurlino; Maud Urbanski; Hariharan Venkatesan; Aihua Wang; Craig R. Woods; Xiaohua Xue; James P. Edwards; Anne Fourie; Kristi A. Leonard
A high-throughput screen of the ligand binding domain of the nuclear receptor retinoic acid-related orphan receptor gamma t (RORγt) employing a thermal shift assay yielded a quinoline tertiary alcohol hit. Optimization of the 2-, 3- and 4-positions of the quinoline core using structure-activity relationships and structure-based drug design methods led to the discovery of a series of modulators with improved RORγt inhibitory potency and inverse agonism properties.
Bioorganic & Medicinal Chemistry Letters | 2017
J. Kent Barbay; Maxwell D. Cummings; Marta Cristina Abad; Glenda Castro; Kevin D. Kreutter; David A. Kummer; Umar Maharoof; Cynthia M. Milligan; Rachel Nishimura; Joan Pierce; Celine Schalk-Hihi; John Spurlino; Virginia M. Tanis; Maud Urbanski; Hariharan Venkatesan; Aihua Wang; Craig R. Woods; Ronald L. Wolin; Xiaohua Xue; James P. Edwards; Anne Fourie; Kristi A. Leonard
We identified 6-substituted quinolines as modulators of the retinoic acid receptor-related orphan receptor gamma t (RORγt). The synthesis of this class of RORγt modulators is reported, and optimization of the substituents at the quinoline 6-position that produced compounds with high affinity for the receptor is detailed. This effort identified molecules that act as potent, full inverse agonists in a RORγt-driven cell-based reporter assay. The X-ray crystal structures of two full inverse agonists from this chemical series bound to the RORγt ligand binding domain are disclosed, and we highlight the interaction of a hydrogen-bond acceptor on the 6-position substituent of the inverse agonist with Glu379:NH as a conserved binding contact.
Archive | 2013
Kristi A. Leonard; Kent Barbay; James P. Edwards; Kevin D. Kreutter; David A. Kummer; Umar Maharoof; Rachel Nishimura; Maud Urbanski; Hariharan Venkatesan; Aihua Wang; Ronald L. Wolin; Craig R. Woods; Anne Fourie; Xiaohua Xue; Maxwell D. Cummings
Archive | 2006
Nand Baindur; Michael David Gaul; Kevin D. Kreutter; Christian Andrew Baumann; Alexander Kim; Guozhang Xu; Robert W. Tuman; Dana L. Johnson
Archive | 2006
Michael David Gaul; Kevin D. Kreutter; Christian Andrew Baumann
Archive | 2006
Kevin D. Kreutter; Tianbao Lu; Yu Kai Lee; Christopher A. Teleha; Mark R. Player; Xizhen Zhu
Archive | 2007
Mark R. Player; Tianbao Lu; Huaping Hu; Xizhen Zhu; Christopher A. Teleha; Kevin D. Kreutter
Archive | 2013
Kristi A. Leonard; Kent Barbay; James P. Edwards; Kevin D. Kreutter; David A. Kummer; Umar Maharoof; Rachel Nishimura; Maud Urbanski; Hariharan Venkatesan; Aihua Wang; Ronald L. Wolin; Craig R. Woods; Anne Fourie; Xiaohua Xue; Maxwell D. Cummings; William M. Jones; Steven Goldberg
Archive | 2006
Nand Baindur; Michael David Gaul; Kevin D. Kreutter; Christian Andrew Baumann; Guozhang Xu; Alexander Kim; Bao-Ping Zhao
Archive | 2013
Kristi A. Leonard; Kent Barbay; James P. Edwards; Kevin D. Kreutter; David A. Kummer; Umar Maharoof; Rachel Nishimura; Maud Urbanski; Hariharan Venkatesan; Aihua Wang; Ronald L. Wolin; Craig R. Woods; Anne Fourie; Xiaohua Xue; Taraneh Mirzadegan; Kelly Lynn Ganamet